JPMorgan Chase & Co. grew its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Free Report) by 49.3% in the ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

They call themselves Speed to Market, a group of life sciences and real estate professionals who find, build, and sell manufacturing space for biotech employers around Philadelphia. During the COVID ...

The proposed funds, which include the VanEck Solana Trust, 21Shares Core Solana ETF, Canary Solana ETF, and Bitwise Solana ...

Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report) fell 3.9% on Friday . The company traded as low as $10.46 and last traded at $10.36. 8,771 shares changed hands during mid-day trading, a ...

The House Oversight Committee is asking "tech leaders who have spoken publicly about debanking to share their stories." ...

Kevin Willsey, a JPMorgan Chase & Co. global chair of investment banking and capital markets, is retiring after more than ...

Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

Some of the other senior executives at the bank also saw their compensation rising by between 4% and 21% in 2024.

JPMorgan Chase said Thursday that long-serving CEO Jamie Dimon’s 2024 pay package climbed about 8.3% to $39 million after the bank posted a record profit amid a revival in dealmaking and fundraising ...

JPMorgan Chase said on Thursday that long-serving CEO Jamie Dimon's 2024 pay package climbed about 8.3% to $39 million after ...

Jamie Dimon was awarded an 8.3% pay raise following a year of record profitability at JPMorgan and amid questions about who ...